Hospital Acquired Disease Testing Market (Pneumonia, UTI, Blood Stream, Surgical Site, MRSA Infection, and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast to 2019

North America dominates the global hospital acquired disease testing market and is followed by Europe. Government initiatives to control and prevent nosocomial infection in these regions and their rigorous implementation to reduce the disease morbidity rate is driving the growth of nosocomial infection testing market.


Albany, NY -- (SBWIRE) -- 12/09/2015 -- This report covers the market analysis for various diagnostic tests performed to detect hospital associated infections, also called as nosocomial infections. These infections are not present in an individual before being admitted to hospital; instead the infections are developed after the admittance. Pathogens, primarily viral, bacterial and fungal are the main cause for the prevalence of nosocomial infections as they spread easily through the individual's body and thereby deteriorate the immune system. The infections are mainly acquired from other patients, hospital staff, and contaminated objects, acting as potential vectors. Morbidity rate of nosocomial infections is increasing rapidly worldwide, hence driving the hospital associated infection (HAI) diagnostic market towards remarkable growth. The stakeholders for this study include manufacturers and providers of diagnostic solutions for nosocomial infections. Therefore, the global hospital acquired disease testing market possesses tremendous growth potential, especially in the developing nations.

Complete Report with TOC @

This research report provides a detailed analysis of the global hospital acquired disease testing market and also aids in understanding the various driving factors for the growth of this market. The executive summary comprises the market snapshot which provides information about segments and sub-segments. The market overview section of the report demonstrates market dynamics and market trends such as the drivers, restraints and opportunities that influence the current nature and future status of this market. Impact factors such as market attractiveness analysis and Porter's five forces analysis of key market players have also been explained in the market overview section of the report, in order to give a thorough analysis of the overall competitive scenario in the hospital acquired disease testing market. All these factors would help the market players to gain thorough analysis of the overall competitive scenario and thereby decide upon the business strategies and plans to be incurred in future for the global hospital acquired disease testing market.

The global hospital acquired disease testing market is categorized on the basis of infection types and geography. The market estimates from 2011 to 2019 for each of these segments is provided in USD million. The global hospital acquired disease testing market, based on the type of infection is segmented into urinary tract infection (UTI) testing, surgical site infection(SSI) testing, pneumonia testing, blood stream infection (BSI) testing, methicillin-resistant staphylococcus aureus (MRSA) testing, and others (GI, bone, respiratory, cardiovascular, etc.). A detailed market analysis and forecast for these segments has been provided in this study in terms of market revenue (USD million) for the period 2011 to 2019. The report also provides the compounded annual growth rate (CAGR %) for each infection type for the forecast period 2013 to 2019, while market size estimations have been made considering 2012 as the base year.

Get Discount on this report @

Based on geography, the global hospital acquired disease testing market has been segmented into four major regions: North America, Europe, Asia Pacific and Rest of the World. The current and future market sizes (in terms of USD million) of the above regional markets have been provided in the report for the period 2011 to 2019 with their growth rate (%) for the period 2013 to 2019. The study further offers recommendations and highlights of the market, which would be useful for the existing and new market players to sustain and grow in the global hospital acquired disease testing market.

This report concludes with the company profiles section which includes key information such as company overview, financial overview, product portfolio, business strategies and recent developments about the major market players in hospital acquired disease testing market. Some of the key players profiled in this report include Diatherix Laboratories, Inc., Gen-Probe, Inc., Qiagen GmbH, L Hoffman La Roche,Cepheid, Inc., Life Technologies Corporation, Meridian Biosciences, Cantel Medical Corporation, Nordion, Inc.and others.

Request a Free Sample Copy of the Report @

MRRSE stands for Market Research Reports Search Engine, the largest online catalog of latest market research reports based on industries, companies, and countries. MRRSE sources thousands of industry reports, market statistics, and company profiles from trusted entities and makes them available at a click. Besides well-known private publishers, the reports featured on MRRSE typically come from national statistics agencies, investment agencies, leading media houses, trade unions, governments, and embassies.